In view of the apparent alternative pathway activation, the von Willebrand factor was measured, as this has been shown to be an important modulator in the pathway and was shown to be elevated in PCOS (p = 0.04) (Table 2). This evidence concerns the gene VWF and polycystic ovary syndrome.